Product Information
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1518 per EA under NDC 59746079901. Its NADAC has been published 50 times since Sep 10, 2025.
FDA first approved this application on Sep 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746079901
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090802FDA Approved
9/28/2012
TE Code
AB
On Market Since
11/30/2024
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has been published 50 times since Sep 10, 2025, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1518 per EA |
|---|---|
| All-time high | $0.1729 (Sep 10, 2025) |
| All-time low | $0.1513 (Jul 22, 2026) |
| 52-week high | $0.1729 |
| 52-week low | $0.1513 |
| Median price | $0.1672 |
| Average price | $0.1649 |
| Largest weekly change | -3.2% (Jun 17, 2026) |
| Weeks tracked | 50 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1518 per EA (NDC 59746079901), effective Aug 19, 2026.
How has the price of TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has declined 12.2%. It has been tracked across 50 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
Since Sep 10, 2025, the NADAC for TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1513 (Jul 22, 2026) to a high of $0.1729 (Sep 10, 2025), with a median of $0.1672 per EA.
Are there cheaper alternatives to TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) in a comparable dosage form, but none are currently priced below it.
Who manufactures TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) (NDC 59746079901) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.